|

[225Ac]Ac-A9-3408 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Alpha-9 Oncology USA Inc.1

Indications

  • Uveal Melanoma, Metastatic1
  • Melanoma Metastatic1
  • Mucosal Melanoma1
  • Cancer1

Other1 trial

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.